Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

ACHV | Achieve Life Sciences Inc.

Healthcare | Biotechnology | Canada | NASD

Index	-	P/E	-	EPS (ttm)	-3.11	Insider Own	17.42%	Shs Outstand	17.90M	Perf Week	-1.38%
Market Cap	90.77M	Forward P/E	-	EPS next Y	-1.61	Insider Trans	0.14%	Shs Float	17.43M	Perf Month	-11.89%
Income	-41.54M	PEG	-	EPS next Q	-0.37	Inst Own	25.80%	Short Float / Ratio	4.02% / 12.76	Perf Quarter	-17.15%
Sales	0.00M	P/S	-	EPS this Y	58.35%	Inst Trans	2.34%	Short Interest	0.70M	Perf Half Y	-31.96%
Book/sh	0.46	P/B	9.36	EPS next Y	3.12%	ROA	-132.08%	Target Price	24.86	Perf Year	28.74%
Cash/sh	1.19	P/C	3.62	EPS next 5Y	15.00%	ROE	-363.35%	52W Range	2.00 - 10.30	Perf YTD	75.51%
Dividend	-	P/FCF	-	EPS past 5Y	60.98%	ROI	-163.11%	52W High	-58.25%	Beta	1.54
Dividend %	-	Quick Ratio	7.65	Sales past 5Y	0.00%	Gross Margin	-	52W Low	115.00%	ATR	0.24
Employees	20	Current Ratio	7.65	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	34.50	Volatility	4.93% 5.59%
Optionable	Yes	Debt/Eq	1.63	EPS Q/Q	60.14%	Profit Margin	-	Rel Volume	0.90	Prev Close	4.30
Shortable	Yes	LT Debt/Eq	1.63	Earnings	Aug 14 AMC	Payout	-	Avg Volume	54.90K	Price	4.30
Recom	1.00	SMA20	-8.45%	SMA50	-13.96%	SMA200	-20.21%	Volume	49,478	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
May-10-23	Reiterated	Maxim Group	Buy	$8 → $20
Jun-23-21	Initiated	Oppenheimer	Outperform	$23

Sep-11-23 08:00AM	Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting (GlobeNewswire)
Sep-07-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire) -5.24%
Aug-16-23 10:30AM	ACHV: 2Q:23 Results (Zacks)
Aug-15-23 10:25PM	Q2 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:00PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update (GlobeNewswire)
08:00AM	Loading…
Aug-01-23 08:00AM	Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast (GlobeNewswire)
Jul-18-23 08:00AM	Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting (GlobeNewswire)
Jul-11-23 11:23AM	Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA) (GlobeNewswire)
Jun-06-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
May-25-23 09:00AM	Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering (GlobeNewswire) -6.07%
07:16AM	ACHV: ORCA-3 Topline (Zacks Small Cap Research)
May-24-23 06:10AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Shift From Loss To Profit (Simply Wall St.)
May-23-23 02:46PM	Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial (Benzinga) -23.80%
06:00AM	Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial (GlobeNewswire)
May-17-23 08:00AM	Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank (GlobeNewswire)
09:08AM	Loading…
May-10-23 09:08AM	ACHV: First Quarter Results (Zacks Small Cap Research) +12.71%
05:57AM	Q1 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-23 04:05PM	Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Apr-26-23 08:00AM	Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023 (GlobeNewswire)
Apr-24-23 05:27AM	ACHV: ORCA-V1 Readout (Zacks Small Cap Research)
Apr-20-23 02:22PM	Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment (Benzinga)
08:00AM	Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline (GlobeNewswire)
Apr-14-23 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference (GlobeNewswire)
Mar-30-23 08:00AM	Achieve Life Sciences Announces Refresh to Board of Directors (GlobeNewswire) +5.86%
Mar-29-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.57%
Mar-20-23 10:46PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2022 Earnings Call Transcript (Insider Monkey)
05:27AM	ACHV: 2022 Financial and Operational Results (Zacks Small Cap Research)
Mar-17-23 08:00AM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
05:48AM	Q4 2022 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-16-23 04:05PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update (GlobeNewswire)
08:00AM	Loading…
Mar-08-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Mar-03-23 08:00AM	Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire) +7.79%
Mar-02-23 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023 (GlobeNewswire)
Feb-15-23 05:42AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) top owners are individual investors with 56% stake, while 43% is held by institutions (Simply Wall St.) -15.52%
Feb-07-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Feb-02-23 08:00AM	Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-27-23 04:30PM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
Jan-09-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.28%
Dec-29-22 06:02AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-21-22 08:00AM	Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation (GlobeNewswire)
Nov-21-22 06:01AM	ACHV: 3Q:22 Results: Target Enrollments Reached (Zacks Small Cap Research)
Nov-15-22 08:00AM	Achieve Life Sciences Announces Private Placement of $18.9 Million (GlobeNewswire) +5.45%
Nov-14-22 04:05PM	Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Nov-08-22 08:00AM	Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial (GlobeNewswire)
Oct-31-22 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022 (GlobeNewswire)
Sep-27-22 08:00AM	Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) -7.42%
Sep-07-22 08:00AM	Achieve Life Sciences Announces Participation at Fall Investor Conferences (GlobeNewswire)
Aug-15-22 06:16AM	ACHV: Autumn Enrollment Completion for ORCA-3 (Zacks Small Cap Research) +12.80%
Aug-11-22 04:05PM	Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Jul-28-22 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022 (GlobeNewswire)
Jul-01-22 04:05PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
Jun-29-22 08:00AM	Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation (GlobeNewswire)
Jun-21-22 08:00AM	Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference (GlobeNewswire)
Jun-01-22 08:00AM	Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users (GlobeNewswire)
May-26-22 08:00AM	Achieve Life Sciences Announces Participation at LD Micro Invitational Conference (GlobeNewswire)
May-16-22 01:20PM	36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 (ACCESSWIRE)
May-13-22 08:00AM	Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference (GlobeNewswire)
06:30AM	ACHV: First Quarter 2022 Results (Zacks Small Cap Research)
May-12-22 04:00PM	Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update (GlobeNewswire)
May-05-22 02:59PM	Health Check: How Prudently Does Achieve Life Sciences (NASDAQ:ACHV) Use Debt? (Simply Wall St.)
Apr-28-22 05:22AM	ACHV: Topline Data from ORCA-2 Smoking Cessation Trial (Zacks Small Cap Research) -6.46%
Apr-27-22 09:40AM	Achieve Life Sciences Aces Pivotal Cytisinicline Study In Smoking Cessation (Benzinga) +7.68%
08:00AM	Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers (GlobeNewswire)
Apr-21-22 08:00AM	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022 (GlobeNewswire)
Mar-15-22 08:00AM	Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire)
Mar-14-22 08:00AM	Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors (GlobeNewswire)
Mar-11-22 08:06AM	ACHV: 2021 Results: ORCA-3 Underway, ORCA-V1 Soon to Start (Zacks Small Cap Research)
08:00AM	Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award (GlobeNewswire)
Mar-10-22 08:00AM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update (GlobeNewswire)
Mar-08-22 08:00AM	Achieve Life Sciences Announces Participation in March Investor Conferences (GlobeNewswire)
Feb-24-22 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022 (GlobeNewswire)
Feb-04-22 04:37AM	ACHV: The Final Phase III Begins (Zacks Small Cap Research)
Feb-03-22 08:00AM	Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Award (GlobeNewswire)
Feb-02-22 08:00AM	Achieve Life Sciences Announces Participation in February Investor Conferences (GlobeNewswire)
Jan-28-22 10:07AM	36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022 (ACCESSWIRE)
Jan-25-22 11:08AM	Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation (Benzinga)
08:00AM	Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline for Smoking Cessation (GlobeNewswire)
Jan-06-22 08:30AM	Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT Virtual Conference (GlobeNewswire)
Jan-04-22 08:30AM	Achieve Life Sciences Announces Completion of Last Subject, Last Follow-Up Visit in Phase 3 ORCA-2 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire)
Dec-22-21 12:16PM	Achieve Life Sciences Secures $25M Loan Facility To Fund Smoking Cessation Program (Benzinga)
08:30AM	Achieve Life Sciences Announces $25 Million Loan Facility from Silicon Valley Bank to Fund Cytisinicline Smoking Cessation Clinical Development (GlobeNewswire)
Nov-23-21 08:30AM	Achieve Life Sciences to Host Key Opinion Leader Panel on Smoking and e-Cigarette Cessation (GlobeNewswire)
Nov-22-21 08:30AM	Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline in Smoking Cessation Clears Final Review by Data Safety Monitoring Committee (DSMC) (GlobeNewswire)
Nov-11-21 04:20AM	We Think Achieve Life Sciences (NASDAQ:ACHV) Needs To Drive Business Growth Carefully (Simply Wall St.)
03:00AM	ACHV: Early 2022 Start to ORCA-3 and ORCA-V1 (Zacks Small Cap Research)
Nov-09-21 04:05PM	Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development (GlobeNewswire)
Nov-04-21 08:30AM	Achieve Life Sciences Announces Participation in November Investor Conferences (GlobeNewswire)
Nov-02-21 01:03PM	Achieve Life Sciences To Start Cytisinicline's Trial For Nicotine E-cigarette Cessation (Benzinga)
08:30AM	Achieve Life Sciences Announces FDA Acceptance of IND Application for Cytisiniclines Second Planned Indication for Nicotine E-cigarette Cessation (GlobeNewswire)
Oct-26-21 08:30AM	Achieve Life Sciences to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 9, 2021 (GlobeNewswire)
Sep-15-21 05:30AM	Achieve Life Sciences to Participate in Upcoming Investor Conferences (ACCESSWIRE)
Sep-14-21 05:30AM	Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference (ACCESSWIRE)
Sep-09-21 05:30AM	Achieve Life Sciences to Participate in Two Upcoming Investor Conferences (ACCESSWIRE)
Aug-16-21 05:10AM	ACHV: ORCA-2 Fully Enrolled (Zacks Small Cap Research) -6.46%
Aug-13-21 05:30AM	Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards (ACCESSWIRE)
Aug-11-21 04:05PM	Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update (ACCESSWIRE) +8.06%
05:30AM	Achieve Announces Two Patents Granted by USPTO for Novel Cytisinicline Dosing and Administration Regimen (ACCESSWIRE)
Aug-03-21 05:30AM	Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021 (ACCESSWIRE)
Jul-22-21 09:35AM	Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use (ACCESSWIRE)
Jul-12-21 05:57AM	ACHV: Longer Patents, Higher Valuation (Zacks Small Cap Research)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bencich John	CEO	May 30	Buy	5.50	5,000	27,500	66,730	Jun 01 05:42 PM
JACOBS CINDY	President & CMO	Apr 28	Option Exercise	0.00	2,500	0	18,870	May 01 05:54 PM
Wan Jerry	Principal Accounting Officer	Apr 28	Option Exercise	0.00	1,250	0	7,101	May 01 05:55 PM
Bencich John	CEO	Apr 28	Option Exercise	0.00	7,500	0	63,557	May 01 05:53 PM
Stewart Richard Alistair	Executive Chairman	Apr 28	Option Exercise	0.00	5,000	0	30,751	May 01 05:51 PM
Wan Jerry	Principal Accounting Officer	Apr 21	Option Exercise	0.00	5,625	0	8,861	Apr 24 04:17 PM
Stewart Richard Alistair	Executive Chairman	Apr 21	Option Exercise	0.00	22,500	0	35,876	Apr 24 04:15 PM
JACOBS CINDY	President & CMO	Apr 21	Option Exercise	0.00	16,250	0	20,181	Apr 24 04:14 PM
Bencich John	CEO	Apr 21	Option Exercise	0.00	25,000	0	61,920	Apr 24 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACHV | Achieve Life Sciences Inc.

Upgrade your FINVIZ experience